Arrowstreet Capital’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
+40,211
New +$1.27M ﹤0.01% 1502
2025
Q2
Sell
-282,275
Closed -$6.46M 2065
2025
Q1
$6.46M Buy
+282,275
New +$6.81M 0.01% 944
2024
Q3
Sell
-20,381
Closed -$604K 1852
2024
Q2
$604K Sell
20,381
-99,416
-83% -$2.76M ﹤0.01% 1309
2024
Q1
$3.61M Buy
119,797
+97,060
+427% +$2.69M ﹤0.01% 984
2023
Q4
$651K Buy
+22,737
New +$668K ﹤0.01% 1182
2023
Q2
Sell
-26,043
Closed -$951K 1447
2023
Q1
$951K Buy
+26,043
New +$822K ﹤0.01% 1076

Other funds holding RTO

Arrowstreet Capital's RTO Position: Q1 2026 in Review

Arrowstreet Capital opened a new position in Rentokil (RTO) in Q1 2026: 40,211 shares worth $1.27M. The stake represents ﹤0.01% of the portfolio and ranks #1502 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in RTO as recently as Q1 2025.

Arrowstreet Capital first reported a position in RTO in Q1 2023 and has held it in 6 quarters since. The position peaked at $6.46M in Q1 2025. 283 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Arrowstreet Capital held 40,211 shares of Rentokil worth $1.27M as of Q1 2026.
  • Rentokil was a new Arrowstreet Capital position in Q1 2026.
  • Rentokil made up ﹤0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #1502 holding.
  • Arrowstreet Capital first reported a position in Rentokil in Q1 2023 and has held it in 6 quarters since.
  • Arrowstreet Capital's Rentokil position peaked at $6.46M in Q1 2025.
  • 283 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.